Melbourne: A drug originally developed to treat leukaemia is effective in the prevention of asthma by targeting its causative mechanisms rather than just treating the symptoms, a new research has found.The research centres on the role played by two proteins in the lungs in causing asthma attacks.When these proteins come into contact with the common cold virus and dust mites, the two main asthma triggers, they work together to produce a series of events that cause an attack, researchers said in a statement.The study shows that a compound in the drug is able to activate a protein that is suppressed during asthma. This could mean that in the future doctors would be able to treat the cause of asthma, not just the symptoms."Asthma is one of the major diseases of the developed world. It`s very rare to find a compound that can reverse the symptoms of asthma," said Dr Anthony Don, who started working on the compound in the treatment of acute myeloid leukaemia.
Stem cell jab may aid stroke recovery: Study
Protein that can stop breast cancer from spreading found